Arena Pharmaceuticals Inc buy melinda
Summary
This prediction ended on 22.07.19 with a price of €56.26. The prediction had a final performance of 15.78%. melinda has 50% into this predictionArena Pharmaceuticals, Inc. (Symbol ARNA) is a biopharmaceutical company based in San Diego, California that focuses on the research, development, and commercialization of novel medications. The company's primary focus is on developing small molecule drugs that target G protein-coupled receptors, which are involved in a wide range of physiological processes. Arena has a diverse pipeline of potential drug candidates in various stages of development, including treatments for pulmonary arterial hypertension, pain, autoimmune diseases, and more. The company's stock is listed on the NASDAQ exchange and is widely considered to be a high-risk/high-reward investment.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Arena Pharmaceuticals Inc | - | - | - | - |
iShares Core DAX® | 1.164% | 1.549% | 24.351% | 23.659% |
iShares Nasdaq 100 | 0.118% | 0.969% | 28.865% | 41.786% |
iShares Nikkei 225® | 1.124% | -1.120% | 17.443% | 6.454% |
iShares S&P 500 | 0.479% | 1.068% | 28.585% | 42.511% |
Comments by melinda for this prediction
In the thread Arena Pharmaceuticals Inc diskutieren
cliniques expérimentaux : etrasimod (APD334) en phase II pour le traitement de... Lire la suite Secteur Recherche biotechnologique et médicale Agenda 13/06 Assemblée générale
Stopped prediction by melinda for Arena Pharmaceuticals Inc
Arena Pharmaceuticals Inc
21.05.20
04.11.21
05.11.21
Arena Pharmaceuticals Inc
03.01.18
21.03.18
21.03.18
Arena Pharmaceuticals Inc
20.09.13
20.03.14
20.03.14
Arena Pharmaceuticals Inc
21.12.10
23.12.10
23.12.10
Arena Pharmaceuticals Inc
18.09.10
21.12.10
21.12.10